Cargando…

Improved Pharmacokinetics of Sumatriptan With Breath Powered™ Nasal Delivery of Sumatriptan Powder

OBJECTIVES.—: The purpose of this study was to directly compare the pharmacokinetic (PK) profile of 22-mg sumatriptan powder delivered intranasally with a novel Breath Powered™ device (11 mg in each nostril) vs a 20-mg sumatriptan liquid nasal spray, a 100-mg oral tablet, and a 6-mg subcutaneous inj...

Descripción completa

Detalles Bibliográficos
Autores principales:	Obaidi, Mohammad, Offman, Elliot, Messina, John, Carothers, Jennifer, Djupesland, Per G, Mahmoud, Ramy A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2013
Materias:	Research Submissions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232272/ https://www.ncbi.nlm.nih.gov/pubmed/23992438 http://dx.doi.org/10.1111/head.12167

Ejemplares similares

A Randomized, Double-Blind, Placebo-Controlled Study of Breath Powered Nasal Delivery of Sumatriptan Powder (AVP-825) in the Treatment of Acute Migraine (The TARGET Study)
por: Cady, Roger K, et al.
Publicado: (2015)

AVP-825 Breath-Powered Intranasal Delivery System Containing 22 mg Sumatriptan Powder vs 100 mg Oral Sumatriptan in the Acute Treatment of Migraines (The COMPASS Study): A Comparative Randomized Clinical Trial Across Multiple Attacks
por: Tepper, Stewart J, et al.
Publicado: (2015)

Evaluation of the Pharmacokinetic Interaction of Ubrogepant Coadministered With Sumatriptan and of the Safety of Ubrogepant With Triptans
por: Jakate, Abhijeet, et al.
Publicado: (2020)

Breath-powered sumatriptan dry nasal powder: an intranasal medication delivery system for acute treatment of migraine
por: Tepper, Stewart J, et al.
Publicado: (2018)

Breath Powered Nasal Delivery: A New Route to Rapid Headache Relief
por: Djupesland, Per G, et al.
Publicado: (2013)

Metabolism of sumatriptan revisited
por: Pöstges, Timo, et al.
Publicado: (2023)

Functional Hybrid Nanoemulsions for Sumatriptan Intranasal Delivery
por: Ribeiro, Lígia N. M., et al.
Publicado: (2020)

Subcutaneous delivery of sumatriptan in the treatment of migraine and primary headache
por: Moore, Johanna C, et al.
Publicado: (2012)

Harnessing Intranasal Delivery Systems of Sumatriptan for the Treatment of Migraine
por: Assadpour, Sara, et al.
Publicado: (2022)

Efficacy of Sumatriptan/Placebo versus Sumatriptan/Propofol Combination in Acute Migraine; a Randomized Clinical Trial
por: Farahmand Rad, Reza, et al.
Publicado: (2022)

Pharmacokinetics study of chitosan-coated liposomes containing sumatriptan in the treatment of migraine
por: Assadpour, Sara, et al.
Publicado: (2022)

Pharmacokinetics of sumatriptan in non-respondent and in adverse drug reaction reporting migraine patients
por: Sternieri, E., et al.
Publicado: (2005)

Spontaneous splenic infarction associated with sumatriptan use
por: Arora, A., et al.
Publicado: (2006)

Bilateral Renal Infarctions During the Use of Sumatriptan
por: Abramovitz, Blaise, et al.
Publicado: (2018)

NAVIGATE I: Randomized, Placebo-Controlled, Double-Blind Trial of the Exhalation Delivery System With Fluticasone for Chronic Rhinosinusitis With Nasal Polyps
por: Sindwani, Raj, et al.
Publicado: (2018)

Subcutaneous sumatriptan delivery devices: comparative ease of use and preference among migraineurs
por: Andre, Anthony D, et al.
Publicado: (2017)

In vivo bioavailability studies of sumatriptan succinate buccal tablets
por: Shivanand, K, et al.
Publicado: (2011)

Effect of CGRP and sumatriptan on the BOLD response in visual cortex
por: Asghar, Mohammad S., et al.
Publicado: (2012)

Influence of sumatriptan on the autonomic system during migraine attacks
por: Dalla Volta, G., et al.
Publicado: (2006)

Formulation and evaluation of bucco-adhesive tablets of sumatriptan succinate
por: Prasanna, R Indira, et al.
Publicado: (2011)

Formulation and evaluation of sublingual tablets containing Sumatriptan succinate
por: Prajapati, Shailesh T, et al.
Publicado: (2012)

Inhibition of voltage-gated sodium channels by sumatriptan bioisosteres
por: Carbonara, Roberta, et al.
Publicado: (2015)

Sumatriptan ameliorates renal injury induced by cisplatin in mice
por: Bazmandegan, Gholamreza, et al.
Publicado: (2019)

Evaluation of sex differences in the pharmacokinetics of oral sumatriptan in healthy Korean subjects using population pharmacokinetic modeling
por: Ohk, Boram, et al.
Publicado: (2022)

Treatment satisfaction and efficacy of the rapid release formulation of sumatriptan 100 mg tablets utilising an early intervention paradigm in patients previously unsatisfied with sumatriptan
por: Newman, L C, et al.
Publicado: (2008)

Development and Evaluation of in-situ Nasal Gel Formulations of Nanosized Transferosomal Sumatriptan: Design, Optimization, in vitro and in vivo Evaluation
por: Omar, Mahmoud M, et al.
Publicado: (2019)

Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey
por: Jeong, Hyo-Jin, et al.
Publicado: (2008)

Does sumatriptan cross the blood–brain barrier in animals and man?
por: Tfelt-Hansen, Peer Carsten
Publicado: (2009)

Sumatriptan and dihydroergotamine in proximal and distal human isolated coronary arteries
por: Labruijere, S, et al.
Publicado: (2013)

EHMTI-0096. Efficacy of sumatriptan: assessment of a possible biomarker
por: Ibrahimi, K, et al.
Publicado: (2014)

Comparative Study of Different Combinational Mucoadhesive Formulations of Sumatriptan-Metoclopramide
por: Jelvehgari, Mitra, et al.
Publicado: (2016)

Pre-treatment with sumatriptan for cilostazol induced headache in healthy volunteers
por: Falkenberg, Katrine, et al.
Publicado: (2018)

Sumatriptan-induced angle-closure glaucoma: A case report
por: Hsu, Cherng-Ru, et al.
Publicado: (2017)

Investigation of sumatriptan and ketorolac trometamol in the human experimental model of headache
por: Ghanizada, Hashmat, et al.
Publicado: (2020)

The Use of Neuroimaging for Predicting Sumatriptan Treatment Response in Patients With Migraine
por: Wu, Jr-Wei, et al.
Publicado: (2022)

Sumatriptan Induced Takotsubo Cardiomyopathy; the Headache of the Heart: A Case Report
por: Mohan, Jay, et al.
Publicado: (2019)

The pathophysiology of Sumatriptan induced non-arteritic anterior ischemic optic neuropathy
por: Dăscălescu, Dana, et al.
Publicado: (2022)

Sumatriptan poisoning and its clinical presentation in humans: A case report
por: Erfan Talab Evini, Peyman, et al.
Publicado: (2022)

Use of factorial design in formulation and evaluation of intrarectal in situ gel of sumatriptan
por: Kassab, Hanan J., et al.
Publicado: (2023)

Determination of sumatriptan in human plasma using liquid chromatography-mass spectrometry for pharmacokinetic study in healthy Korean volunteers
por: Cho, Seungil, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_itjq61jmoo2ffkkdm83p2vc7bh